Zhongnan Medical Journal Press

Home Results

A total of 8 result was found. Results that relate to Dapagliflozin

Dapagliflozin in the treatment of chronic heart failure: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2023,32(5):554-563.
6459 times 1425 times

An-Hua WEI Lu WANG Lu ZENG Xue-Peng GONG Dong LIU

Dapagliflozin Chronic heart failure Effectiveness Safety Economy Rapid health technology assessment
Details
Cost-utility analysis of sacubitril/valsartan, dapagliflozin and empagliflozin in heart failure with reduced ejection fraction

Published on Chinese Journal of Pharmacoepidemiology 2023,32(8):878-885.
3734 times 1094 times

Dan-Dan LU Sheng-Xiang WANG Shan LU Dan PAN Li-Yuan SHI Fei-Chuang Jing2

Heart failure with reduced ejection fraction Sacubitril/valsartan Dapagliflozin Empagliflozin Markov model Cost-utility analysis
Details
Influences of dapagliflozin on blood pressure variability and left ventricular mass index in patients with type 2 diabetes mellitus and hypertension

Published on Frontiers in Pharmaceutical Sciences 2023,36(12):413-419.
3394 times 1444 times

Sa-Sa LI Bei-Bei YE Xin LIU Xia-Ling ZHU

Dapagliflozin Type 2 diabetes mellitus Hypertension Blood pressure variability Left ventricular mass index
Details
Effects of dapagliflozin on myocardial work and energy metabolism in heart failure with reduced ejection fraction patients without type 2 diabetes mellitus

Published on Frontiers in Pharmaceutical Sciences 2024,27(1):100-108.
2894 times 1024 times

LU Qian DENG Yimin YANG Zongwang HUANG He QIN Peng LUO Weilin YE Shaowu

Dapagliflozin Heart failure with reduced ejection fraction Myocardial function Energy metabolism Diabetes
Details
The impact of dapagliflozin on blood glucose and cognitive function in type 2 diabetes patients with ischemic stroke

Published on Frontiers in Pharmaceutical Sciences 2024,28(2):192-199.
3862 times 658 times

YU Meiling ZHANG Xiao LI Ping

Dapagliflozin Type 2 diabetes Ischemic stroke Blood glucose Cognitive function
Details
Signals mining and analysis of adverse drug events of dapagliflozin based on FAERS database

Published on Chinese Journal of Pharmacoepidemiology 2024,33(12):1336-1345.
10904 times 694 times

LI Jiaoyue LIU Yan YANG Qiubo YANG Tianyi DAI Jinlin ZHAO Qiyao LUO Yunpeng LI Ping HUANG Zifan ZHANG Li YANG Xiaohui

Dapagliflozin Sodium-glucose cotransporter 2 inhibitors Adverse drug event FAERS database Signal mining Pharmacovigilance
Details
Evaluation of the efficacy and safety of dapagliflozin and empagliflozin in the treatment of patients with diabetic nephropathy based on real-world data

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):734-742.
947 times 149 times

HU Ruiwen JI Cheng LI Li

Diabetic nephropathy Dapagliflozin Empagliflozin Real world study Efficacy Safety
Details
A case report of acute kidney injury caused by semaglutide in combination with multiple medications

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):835-840.
801 times 119 times

GU Jiamei TANG Chenquan JIANG Yi YIN Hao FENG Chen XUE Yi

Semaglutide Metformin Dapagliflozin Sacubitril/Valsartan Acute kidney injury Adverse reactions
Details